How to Manage Self-Poisoning With Baclofen in Alcohol Use Disorder? Current Updates

被引:5
作者
Franchitto, Nicolas [1 ,2 ,3 ]
Rolland, Benjamin [4 ,5 ]
Pelissier, Fanny [2 ]
Simon, Nicolas [6 ]
机构
[1] Toulouse Purpan Univ Hosp, Dept Addict Med, Toulouse, France
[2] Toulouse Purpan Univ Hosp, Poison Control Ctr, Toulouse, France
[3] Paul Sabatier Univ, UMR 1027, Toulouse, France
[4] SUAL, Pole MOPHA, CH Le Vinatier, Bron, France
[5] Univ Lyon, INSERM, U1028, UCBL,CRNL,CNRS,UMR5292, Lyon, France
[6] Aix Marseille Univ, Hop St Marguerite, AP HM, INSERM,CAP TV,IRD,SESSTIM,Serv Pharmacol Clin, Marseille, France
来源
FRONTIERS IN PSYCHIATRY | 2018年 / 9卷
关键词
baclofen; intoxication/pharmacology; comorbid conditions; seizures; psychiatry; HIGH-DOSE BACLOFEN; EXTRACORPOREAL TREATMENT USEFUL; PLACEBO-CONTROLLED TRIAL; SYMPTOMS CASE-REPORT; DEPENDENT PATIENTS; DOUBLE-BLIND; EFFICACY; OVERDOSE; SAFETY; INTOXICATION;
D O I
10.3389/fpsyt.2018.00417
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Specialists in addiction medicine continue to debate whether baclofen is still indicated to treat alcohol use disorders in view of conflicting results as to its efficacy. This review summarizes current knowledge on self-poisoning with baclofen focusing of alcohol-use disorder in order to provide an overview of the reliable scientific knowledge on management of such an intoxication. Moreover, as alcohol-dependent patients experience many psychiatric co-morbidities, the risk in suicide attempt using baclofen seems real. Numerous studies have suggested that patients given daily-doses of baclofen higher than 80 mg/day are more likely to attempt suicides than others. Following an ingestion of a large amount of baclofen, central nervous system depression is usually observed. Seizures require the patient to be admitted in intensive care unit and should be treated like other toxicological seizures. Cardiac complications include prolonged QTc interval, degree heart block, premature atrial contractions, and supraventricular tachycardia, hypotension and bradycardia. In cases of intoxication, the elimination half-life of baclofen may last between 12 and 36 h post-overdose and renal failure is known to delay its clearance. Rarely measured in clinical practice, the toxic level of baclofen blood level ranges from 1.1 to 3.5 mg/l, and coma or fatal intoxication are observed from 6 to 9.6 mg/l. Baclofen withdrawal has been observed but making the diagnosis of withdrawal in case of suspected self-poisoning is difficult as baclofen intoxication and baclofen withdrawal share many clinical signs. Admission to hospital to manage of suicide attempt with baclofen is mandatory and should not be limited to baclofen alone. It needs to include other aspects of the overall care of patients with alcohol disorders (psychological and psychosocial interventions, management of comorbid mental conditions and physical complications).
引用
收藏
页数:6
相关论文
共 50 条
[41]   Characteristics of the patients treated with high dose baclofen in alcohol use disorder: a regional survey conducted in community pharmacies [J].
Auffret, M. ;
Deheul, S. ;
Caous, A. S. ;
Rolland, B. ;
Bene, J. ;
Bordet, R. ;
Gautier, S. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 :44-44
[42]   Community pharmacists and high dose baclofen in alcohol use disorder: a regional prospective survey concerning their practice with these prescriptions [J].
Auffret, M. ;
Deheul, S. ;
Caous, A. S. ;
Rolland, B. ;
Bene, J. ;
Bordet, R. ;
Gautier, S. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 :44-44
[43]   Life Goals Increase Self-regulation among Male Patients with Alcohol Use Disorder [J].
Won, Sung-Doo ;
Kim, Im-Yel .
SUBSTANCE USE & MISUSE, 2018, 53 (10) :1666-1673
[44]   Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy [J].
Gully, Brian J. ;
Eaton, Erica ;
Capone, Christy ;
Haass-Koffler, Carolina L. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (12) :1182-1189
[45]   Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder [J].
Mason, Barbara J. .
ALCOHOL RESEARCH-CURRENT REVIEWS, 2022, 42 (01)
[46]   How Should Transcranial Direct Current Stimulation be Used in Populations With Severe Alcohol Use Disorder? A Clinically Oriented Systematic Review [J].
Bollen, Zoe ;
Dormal, Valerie ;
Maurage, Pierre .
CLINICAL EEG AND NEUROSCIENCE, 2022, 53 (04) :367-383
[47]   Efficacy and tolerability of baclofen in a US community population with alcohol use disorder: a dose-response, randomized, controlled trial [J].
Garbutt, James C. ;
Kampov-Polevoy, Alexei B. ;
Pedersen, Cort ;
Stansbury, Melissa ;
Jordan, Robyn ;
Willing, Laura ;
Gallop, Robert J. .
NEUROPSYCHOPHARMACOLOGY, 2021, 46 (13) :2250-2256
[48]   A capture-recapture method or estimating the incidence of off-label prescriptions: the example of baclofen or alcohol use disorder in France [J].
Auffret, Marine ;
Rolland, Benjamin ;
Behal, Helene ;
Labreuche, Julien ;
Jouanjus, Emilie ;
Bordet, Regis ;
Gautier, Sophie .
THERAPIE, 2019, 74 (06) :645-650
[49]   Respective influence of current alcohol consumption and duration of heavy drinking on brain morphological alterations in alcohol use disorder [J].
Rolland, Benjamin ;
Dricot, Laurence ;
Creupelandt, Coralie ;
Maurage, Pierre ;
De Timary, Philippe .
ADDICTION BIOLOGY, 2020, 25 (02)
[50]   Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice [J].
Tyson, Luke David ;
Cheng, Alexandra ;
Kelleher, Charles ;
Strathie, Kirstin ;
Lovendoski, James ;
Habtemariam, Zebib ;
Lewis, Heather .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) :567-575